Po‐Chin Liang

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

Pierce K. H. Chow, Mihir Gandhi, Say‐Beng Tan et al. · Journal of Clinical Oncology · 2018 · 650 citations

Medicine, Oncology, Pharmacotherapy +16

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Masatoshi Kudo, Ann‐Lii Cheng, Joong‐Won Park et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 196 citations

Medicine, Oncology, Pharmacology +15

T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis

Ming‐Chu Chang, Yu‐Ting Chang, Yu‐Wen Tien et al. · Clinical Chemistry · 2007 · 157 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

Sheng‐Nan Lu, Jing‐Houng Wang, Chien‐Wei Su et al. · Journal of the Formosan Medical Association · 2017 · 119 citations · Full text

Medicine, Oncology, Surgery +13

Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

Yu‐Yun Shao, Shen-Yung Wang, Shi‐Ming Lin et al. · Journal of the Formosan Medical Association · 2020 · 114 citations · Full text

Medicine, Oncology, Radiology +17